Research output per year
Research output per year
Fingerprint
Dive into the research topics where Claude Wischik is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Rescue of synaptosomal glutamate release defects in tau transgenic mice by the tau aggregation inhibitor hydromethylthionine
Cranston, A., Kraev, I., Stewart, M. G., Horsley, D., Robinson, L., Dreesen, E. S., Armstrong, P., Palliyil, S., Harrington, C., Wischik, C. & Riedel, G., Sept 2024, In: Cellular Signalling. 121, 11 p., 111269.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure) -
Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: interference by cholinesterase inhibitors
Schwab, K., Lauer, D., Magbagbeolu, M., Institute, M., Institute, M., Institute, M., Harrington, C. R., Wischik, C. M., Niewiadomska, G. & Riedel, G., 15 Jun 2024, In: Brain Research Bulletin. 212, 40 p., 110955.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)6 Downloads (Pure) -
Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease
Penny, L. K., Lofthouse, R., Arastoo, M., Porter, A., Palliyil, S., Harrington, C. R. & Wischik, C. M., 21 May 2024, In: Translational neurodegeneration. 13, 14 p., 25.Research output: Contribution to journal › Review article › peer-review
Open AccessFile2 Citations (Scopus)1 Downloads (Pure) -
LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy
Schwab, K., Frahm, S., Magbagbeolu, M., Horsley, D., Goatman, E., Melis, V., Theuring, F., Ishaq, A., Storey, J. M. D., Harrington, C., Wischik, C. & Riedel, G., 5 May 2024, In: European Journal of Pharmacology. 970, 50 p., 176505.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model
Zadrozny, M., Drapich, P., Gasiorowska-Bien, A., Niewiadomski, W., Harrington, C. R., Wischik, C. M., Riedel, G. & Niewiadomska, G., 6 Apr 2024, In: Cells. 13, 7, 27 p., 642.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Downloads (Pure)
Datasets
-
Data from Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: Interference by cholinesterase inhibitors
Schwab, K. (Creator), Lauer, D. (Creator), Magbagbeolu, M. (Creator), Theuring, F. (Creator), Gasiorowska, A. (Creator), Zadrozny, M. (Creator), Harrington, C. (Creator), Wischik, C. (Creator), Niewiadomska, G. (Creator) & Riedel, G. (Creator), University of Aberdeen, Jun 2024
DOI: 10.1016/j.brainresbull.2024.110955, https://ars.els-cdn.com/content/image/1-s2.0-S0361923024000881-mmc1.pdf
Dataset
Impacts
-
Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease
Claude Wischik (Participant), Charles Harrington (Participant), John Storey (Participant), Janet Rickard (Participant), David Horsley (Participant), Thomas Baddeley (Participant), Steven Kemp (Participant), James Sinclair (Participant), Claudia Zabke (Participant), F. Theuring (Participant), F Stamer (Participant) & C Marshall (Participant)
Impact: Health and Wellbeing, Economic and/or Commercial
-
Discovery and development of a new drug for the treatment of dementia
Claude Wischik (Coordinator), Charles Harrington (Coordinator), John Storey (Participant), Janet Rickard (Participant) & David Horsley (Participant)
Impact: Economic and/or Commercial